Categories
Blood-pressure medicinesMedicamentos para la presión arterial降压药降血壓藥AntibioticsAntibióticos抗生素抗生素Diabetes medicinesMedicamentos para la diabetes降糖药降血糖藥Weight-loss medicinesMedicamentos para perder peso减肥药減重藥Cold & cough medicinesMedicamentos para resfriado y tos感冒咳嗽药感冒咳嗽藥Pain & fever reliefAnalgésicos y antitérmicos退烧止痛退燒止痛Allergy medicinesMedicamentos para la alergia抗过敏药抗過敏藥Stomach / acid medicinesMedicamentos gástricos / de acidez胃药胃藥
All categories →
EN ▾
ENES中文繁
⋯
ENES中文繁
All categories →

Coverage & freshness

What each market contributes, how complete it is, and when it was last synced. Counts are records, not unique medicines; a blank/0% means the source does not publish that field.

This page lists data facts only. It does not imply that products are interchangeable, on sale, or equivalent across markets.
Market Products Ingredient mapped Spec coverage Last sync Data as of Known gaps
Australia AU44,79496.7% (43,299/44,794)85.7% (38,367/44,794)2026-10-292026-10-28ARTG export has no registration-status column; status is unknown, not 'on sale'. Some products have no ingredient records.
Canada CA43,847100.0% (43,847/43,847)99.8% (43,776/43,847)2026-10-262026-10-23Full DPD source; non-commercial reuse with attribution.
China CN145,051100.0% (145,051/145,051)96.5% (139,950/145,051)2026-10-262025-04-04No public redistribution licence confirmed; some records have no trade name. · 126,716 (87.4%) no trade-name records
Spain ES25,395100.0% (25,395/25,395)98.0% (24,889/25,395)2026-10-27—Source licence for redistribution is pending confirmation.
European Union (EU) EU2,09590.7% (1,900/2,095)0.0% (0/2,095)2026-11-102026-11-03Regional layer: central authorisations (EMA / EC Union Register). No strength, form or pack size; authorisation ≠ on sale in a country.
United Kingdom GB61,051100.0% (61,051/61,051)84.0% (51,307/61,051)2026-10-262026-10-19Full dm+d source; Open Government Licence attribution.
Hong Kong HK13,935100.0% (13,935/13,935)0.0% (0/13,935)2026-10-292026-10-23Name/ingredient layer only: no strength, form or registration status; registered ≠ marketed.
Mexico MX10,87898.9% (10,757/10,878)35.2% (3,832/10,878)2026-10-25—Source licence is pending confirmation; older registrations are included.
Singapore SG5,51198.8% (5,445/5,511)91.4% (5,038/5,511)2026-10-282026-08-07Registered listing does not prove current supply.
Taiwan TW16,457100.0% (16,457/16,457)47.3% (7,786/16,457)2026-10-282026-10-22Strength is parsed from the product name; confidence is limited.
United States US110,17998.0% (107,950/110,179)87.7% (96,648/110,179)2026-10-252026-10-23Full openFDA source; public-domain US government work.

Sources and licences: see About and docs/许可清单.md. Restricted sources are aggregated only in the data package.